Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-10 10:25 am Sale |
2024-12-31 | 13G | United Therapeutics Corporation UTHR |
WELLINGTON MANAGEMENT CO LLP | 2,463,891 5.500% |
-1,330,119 (-35.06%) |
Filing History |
| 2025-02-05 07:10 am Sale |
2024-12-31 | 13G | United Therapeutics Corporation UTHR |
STATE STREET CORP STT |
2,199,994 4.900% |
-38,230 (-1.71%) |
Filing History |
| 2024-11-08 4:30 pm Sale |
2024-09-30 | 13G | United Therapeutics Corporation UTHR |
ROTHBLATT MARTINE A | 3,194,162 6.800% |
-706,146 (-18.10%) |
Filing History |
| 2024-10-16 1:03 pm Purchase |
2024-09-30 | 13G | United Therapeutics Corporation UTHR |
STATE STREET CORP STT |
2,238,224 5.000% |
2,238,224 (New Position) |
Filing History |
| 2024-06-10 12:15 pm Purchase |
2024-05-31 | 13G | United Therapeutics Corporation UTHR |
The Vanguard Group | 4,687,393 10.570% |
13,715 (+0.29%) |
Filing History |
| 2024-02-14 4:57 pm Sale |
2023-12-31 | 13G | United Therapeutics Corporation UTHR |
ROTHBLATT MARTINE A | 3,900,308 7.800% |
-19,295 (-0.49%) |
Filing History |
| 2024-02-14 09:05 am Sale |
2023-12-31 | 13G | United Therapeutics Corporation UTHR |
AVORO CAPITAL ADVISORS LLC | 2,858,888 6.100% |
-6,112 (-0.21%) |
Filing History |
| 2024-02-13 5:15 pm Purchase |
2023-12-29 | 13G | United Therapeutics Corporation UTHR |
The Vanguard Group | 4,673,678 9.950% |
192,959 (+4.31%) |
Filing History |
| 2024-02-13 09:50 am Sale |
2023-12-29 | 13G | United Therapeutics Corporation UTHR |
Renaissance Technologies LLC | 2,170,214 4.620% |
-174,278 (-7.43%) |
Filing History |
| 2024-02-09 10:05 am Sale |
2024-02-08 | 13G | United Therapeutics Corporation UTHR |
FMR CORP | 2,321,039 4.939% |
-265,765 (-10.27%) |
Filing History |
| 2024-02-08 10:18 am Sale |
2023-12-29 | 13G | United Therapeutics Corporation UTHR |
WELLINGTON MANAGEMENT CO LLP | 3,794,010 8.070% |
-894,814 (-19.08%) |
Filing History |
| 2024-02-08 06:00 am Unchanged |
2023-12-31 | 13G | Celularity Inc. CELU |
UNITED THERAPEUTICS CORP UTHR |
796,885 4.110% |
0 (Unchanged) |
Filing History |
| 2024-01-24 09:46 am Purchase |
2023-12-31 | 13G | United Therapeutics Corporation UTHR |
BLACKROCK INC BLK |
5,294,844 11.300% |
567,858 (+12.01%) |
Filing History |
| 2023-12-22 09:51 am Unchanged |
2023-12-12 | 13D | Miromatrix Medical Inc. MIRO |
UNITED THERAPEUTICS CORP UTHR |
0 0.000% |
0 (Unchanged) |
Filing History |
| 2023-07-10 08:44 am Purchase |
2023-06-30 | 13G | United Therapeutics Corporation UTHR |
WELLINGTON MANAGEMENT CO LLP | 4,688,824 10.010% |
2,119,561 (+82.50%) |
Filing History |
| 2023-03-08 2:19 pm Purchase |
2023-02-28 | 13G | United Therapeutics Corporation UTHR |
BLACKROCK INC BLK |
4,726,986 10.200% |
216,775 (+4.81%) |
Filing History |
| 2023-02-14 09:34 am Sale |
2022-12-31 | 13G | United Therapeutics Corporation UTHR |
AVORO CAPITAL ADVISORS LLC | 2,865,000 6.300% |
-170,000 (-5.60%) |
Filing History |
| 2023-02-13 11:28 am Sale |
2022-12-30 | 13G | United Therapeutics Corporation UTHR |
Renaissance Technologies LLC | 2,344,492 5.140% |
-572,699 (-19.63%) |
Filing History |
| 2023-02-09 12:39 pm Purchase |
2023-02-09 | 13G | United Therapeutics Corporation UTHR |
FMR CORP | 2,586,804 5.675% |
63,426 (+2.51%) |
Filing History |
| 2023-02-09 11:35 am Purchase |
2022-12-30 | 13G | United Therapeutics Corporation UTHR |
The Vanguard Group | 4,480,719 9.830% |
319,756 (+7.68%) |
Filing History |